When the gp100-TCRs were cloned into primary CD8+ T-cells, intracellular cytokine staining by flow cytometry shows that all the TCRs respond to the gp100 index peptide and are capable of killing HLA-A*02 restricted tumour cells. Here, CD8A is linked to neoplasm.